Scientists in China have developed a potential vaccine to prevent the build-up of plaque in arteries that can lead to blood clots, stroke and heart attacks. Atherosclerosis is an inflammatory ...

BEIJING – Inside the Taiwan Hall, one of the many cavernous meeting rooms at the Great Hall of the People named after provinces and regions in China, there is a statue that embodies what is ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study Topline results from ...

It does not necessarily reflect the view of The Herald. A blue plaque could be installed to commemorate a suffragette who spent the last years of her life in Poole. This International Women's Day ...

Once-daily ICP-488 significantly improved PASI scores in patients with plaque psoriasis compared with placebo at week 12. The safety profile of ICP-488 was similar to placebo. ORLANDO — A once ...

(RTTNews) - Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO ...

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study Topline results from ...

A plaque honouring the world’s first black international footballer will be unveiled by England’s first black international Viv Anderson at a Halifax school later this month. Did you know with ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. The findings ...

Using coronary artery calcium (CAC) scoring to guide treatment in intermediate-risk patients, as opposed to usual care, results in a slower development of atherosclerotic plaque, including high-risk ...

Opens in a new tab or window Equipped with knowledge of their coronary artery calcium (CAC) scan results and a statin prescription, patients were more likely to slow their plaque progression over ...